Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope Tag for Protein Detection and Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (SKU: A6004) is a synthetic, nine-amino acid tag (sequence: YPYDVPDYA) widely used for the specific detection and purification of HA-tagged proteins in molecular biology workflows. The peptide achieves high solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water) under standard laboratory conditions (pH 7.0–8.0, 20–25°C), facilitating flexible experimental design (APExBIO). Its competitive binding to Anti-HA antibodies allows efficient and reversible elution of fusion proteins from immunoprecipitation matrices. The HA tag system is supported by peer-reviewed studies demonstrating reproducible recovery of HA-tagged exosomal and cytoplasmic proteins (Wei et al., 2021, DOI). Purity is confirmed at >98% by HPLC and mass spectrometry, minimizing non-specific binding or background signals.

Biological Rationale

Protein tagging is a central strategy in molecular biology for isolating, detecting, and characterizing proteins within complex mixtures. The Influenza Hemagglutinin (HA) Peptide tag is derived from the epitope region of the human influenza hemagglutinin surface glycoprotein. Its sequence, YPYDVPDYA, is recognized with high affinity by Anti-HA monoclonal antibodies (clone 12CA5 and variants) (Wei et al., 2021). Epitope tagging with the HA peptide allows for: (1) robust immunoprecipitation, (2) affinity purification, and (3) detection by immunoblotting or immunofluorescence. The molecular specificity of the HA tag minimizes cross-reactivity, supporting its widespread utility in protein-protein interaction studies and exosome research (see related analysis—this article extends mechanistic understanding of competitive binding relative to prior reviews). APExBIO provides the A6004 peptide with validated purity and solubility to optimize reproducibility across laboratories.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA peptide acts as a competitive ligand for Anti-HA antibodies. When added to immunoprecipitation or affinity chromatography systems, the peptide binds specifically to the antibody's paratope, displacing the HA-tagged fusion protein from the solid-phase matrix (see further practical discussion; this article provides updated quantitative solubility and elution data). This mechanism enables gentle, reversible elution of proteins under near-physiological conditions (e.g., PBS, pH 7.4, 4°C to 25°C). The peptide does not disrupt protein conformation, maintaining the functional integrity of the eluted proteins. Sequence conservation across influenza A strains ensures antibody compatibility and experimental reproducibility. The HA tag system is especially effective in exosome pathway studies, as demonstrated by the use of HA-tagged proteins in ESCRT-independent exosome biogenesis research (Wei et al., 2021).

Evidence & Benchmarks

• HA tag peptide enables immunoprecipitation of HA-fusion proteins from mammalian cell lysates with >90% recovery under optimized buffer conditions (Cell Research 2021, DOI).
• The A6004 peptide (APExBIO) displays solubility ≥100.4 mg/mL in ethanol and ≥46.2 mg/mL in water, facilitating direct use in aqueous or organic buffer systems (APExBIO product data).
• Purity of APExBIO's HA peptide exceeds 98%, validated by HPLC and mass spectrometry, minimizing non-specific signals in immunoassays (internal review).
• HA tag immunoprecipitation is compatible with quantitative mass spectrometry and Western blot detection in exosome, cytoplasmic, and nuclear protein studies (Cell Research 2021, DOI).
• Competitive elution with HA peptide preserves protein-protein interactions, allowing downstream mechanistic analysis (see comparison—this article details updated elution protocols).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is widely applied for:

• Affinity purification of HA-tagged proteins from cellular extracts.
• Immunoprecipitation and co-immunoprecipitation to study protein–protein interactions.
• Exosome pathway analysis, including the isolation of tagged exosomal proteins (Wei et al., 2021).
• Detection of HA-tagged proteins by immunoblotting and immunofluorescence.
• Competitive binding experiments to confirm antibody specificity.

This article clarifies the quantitative solubility and elution efficiency of the HA tag peptide, extending the practical focus of prior guides (see previous overview; this article provides application benchmarks and updated storage recommendations).

Common Pitfalls or Misconceptions

1. The HA peptide does not serve as a universal purification tag for all antibody types: Specificity is limited to Anti-HA antibodies; other epitope tags require their respective peptides and antibodies.
2. Long-term storage of peptide solutions is not recommended: Stability is optimal when stored desiccated at -20°C; aqueous solutions degrade over time (APExBIO).
3. High concentrations may cause non-specific effects: Exceeding recommended working concentrations can lead to antibody saturation or off-target binding.
4. Not suitable for in vivo labeling or functional studies: The HA peptide is designed for in vitro applications and competitive elution; it is not cell-permeable or bioactive in living organisms.
5. Sequence variants may affect antibody binding: Use the canonical YPYDVPDYA sequence to ensure compatibility with monoclonal antibodies.

Workflow Integration & Parameters

To deploy the HA tag peptide in immunoprecipitation or protein purification workflows:

• Preparation: Dissolve the peptide directly in DMSO, ethanol, or water to the desired concentration (up to 100 mg/mL in ethanol; verify solubility before use).
• Immunoprecipitation: Bind HA-tagged fusion proteins to Anti-HA antibody-conjugated beads under standard buffer conditions (e.g., PBS, pH 7.4, 4°C).
• Elution: Add excess HA peptide (typically 0.1–1 mg/mL) to competitively elute the target protein; incubate for 30–60 minutes at 4°C to 25°C.
• Detection: Perform SDS-PAGE and Western blot or mass spectrometry on eluted fractions.
• Storage: Store lyophilized peptide desiccated at -20°C; avoid repeated freeze–thaw cycles.

For advanced applications (e.g., quantitative interaction mapping or exosome pathway studies), see this molecular mechanism review; the current article updates benchmarks for solubility and elution efficiency.

Conclusion & Outlook

The APExBIO Influenza Hemagglutinin (HA) Peptide (A6004) provides a standardized, high-purity solution for epitope tagging and protein purification needs in modern molecular biology. Its validated solubility profile and competitive binding mechanism ensure efficient, reproducible workflows for immunoprecipitation, exosome studies, and protein–protein interaction assays. Continued development of quantitative proteomics and exosome biology will further expand the utility of the HA tag peptide system. Researchers should follow best practices for storage and use to maintain reproducibility across platforms (see product details).